Related Experiment Video
Updated: May 20, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
[Undesired cutaneous adverse drug reactions: What is new?]
1Klinik für Dermatologie, Venerologie und Allergologie, Universität Leipzig, Philipp-Rosenthal-Str. 23, 04103, Leipzig, Deutschland. regina.treudler@uniklinik-leipzig.de
Abstract:
New therapeutic agents, i.e., biologicals, may induce a variety of novel cutaneous adverse reactions (CAR), which hardly can be assigned to existing classification systems. Basing on clinical examples, we present a recently established classification system for CAR to novel drugs. In addition, management strategies for CAR to tumor necrosis factor-α antagonists and to epidermal growth factor receptor inhibitors are discussed.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Allergic Drug Reactions
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions
Transdermal Drug Delivery Systems
